
Additional Web sites:
Food and Drug Administration
American Veterinary Medical Association (AVMA)
American College of Veterinary Internal Medicine (ACVIM)
American Animal Hospital Association (AAHA)
American Association of Veterinary Laboratory Diagnosticians (AAVLD)
California Animal Health and Food Safety (CAHFS)
Upcoming issues of the Diagnostic Edge® newsletter will include additional information on management and monitoring of renal disease. Please sign up to receive Diagnostic Edge® communications.

Category of Disease |
Clinical Signs and Laboratory Results |
Recheck Guidelines |
| Apparently unaffected |
No clinical signs, initial screening labwork normal, urine is concentrated without crystals or casts |
Recheck blood work* and urinalysis 3–4 weeks after last possible exposure to recalled pet food |
| Possible subclinical disease |
No clinical signs, normal renal values, but unconcentrated urine (Specific gravity ≤ 1.030 in dogs, ≤ 1.035 in cats) |
Recheck bloodwork* and urinalysis in one week or sooner if clinical signs develop |
| Mild disease |
Mild azotemia, isosthenuria, casts and/or crystalluria |
Treat and recheck blood work* and urinalysis in 2–3 days |
| Severe disease |
Moderate to severe azotemia and isosthenuria |
Treat aggressively and recheck blood work* and urinalysis in 2–3 days or sooner based on clinical progression |
| |
| Long-Term followup for all patients |
All affected animals should have long-term monitoring of renal parameters, even if initial azotemia and signs resolve with therapy. This may include re-evaluation of bloodwork* and urine 2–4 weeks following initial hospitalization and then every 3–6 months; or more frequently depending on severity of initial disease and persistence of azotemia. |
Please note: These monitoring recommendations are meant as a guideline only. Clinical discretion should be used with each patient based upon complete evaluation of the patient, including history, physical examination and laboratory data.
|